Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice

Human Gene Therapy

Volumn 18, Issue 6, 2007, Pages 490-501

  Xiong, Fu ^a   Xiao, Shaobo ^b   Peng, Funing ^a   Zheng, Hui ^a   Yu, Meijuan ^a   Ruan, Yechun ^a   Li, Wanyi ^a   Shang, Yanchang ^a   Zhao, Cuiping ^a   Zhou, Wenliang ^a   Chen, Huanchun ^b   Chamberlain, Jeffrey S ^c   Fang, Liurong ^b   Zhang, Cheng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DYSTROPHIN; MICRODYSTROPHIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VP22 TEGUMENT PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE TRANSFER; HERPES SIMPLEX VIRUS 1; HISTOPATHOLOGY; MOUSE; MUSCLE CONTRACTILITY; MUSCLE FORCE; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN EXPRESSION; SKELETAL MUSCLE; SOMATIC GENE THERAPY; TIBIALIS ANTERIOR MUSCLE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; WESTERN BLOTTING; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; DYSTROPHIN; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE CONTRACTION; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PHENOTYPE; PHOSPHOPROTEINS; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC; TRANSFECTION; VIRAL STRUCTURAL PROTEINS;

ADENOVIRIDAE; HUMAN HERPESVIRUS 1; MUS; SIMPLEXVIRUS;

EID: 34447118147     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.155     Document Type: Article

References (39)

1. ACSADI, G., LOCHMULLER, H., JANI, A., HUARD, J., MASSIE, B., PRESCOTT, S., SIMONEAU, M., PETROF, B.J., and KARPATI, G. (1996). Dystrophin expression in muscles of mdx mice after adenovirus mediated in vivo gene transfer. Hum. Gene Ther. 72, 129-140.
2. ARAHATA, K., ISHIHARA, T., KAMAKURA, K., TSUKAHARA, T., ISHIURA, S., BABA, C., MATSUMOTO, T., NONAKA, I., and SUGITA, H. (1989). Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy. N. Engl. J. Med. 320, 138-142.
3. BLAKE, D.J., WEIR, A., NEWEY, S.E., and DAVIES, K.E. (2002). Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82, 291-329.
4. BURKHOLDER, T.J., FINGADO, B., BARON, S., and LIEBER, R.L. (1994). Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J. Morphol. 221, 177-190.
5. CASHMAN, S.M., SADOWSKI, S.L., MORRIS, D.J., FREDERICK, J., and KUMAR-SINGH, R. (2002). Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors: Implications for gene therapy. Mol. Ther. 6, 813-823.
6. CHENG, W.F., HUNG, C.F., HSU, K.F., CHAI, C.Y., HE, L., POLO, J.M., SLATER, L.A., LING, M., and WU, T.C. (2002). Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion. Hum. Gene Ther. 13, 553-568.
7. CLOSE, R.I. (1972). Dynamic properties of mammalian skeletal muscles. Physiol. Rev. 52, 129-197.
8. DECONINCK, N., RAGOT, T., MARECHAL, G., PERRICAUDET, M., and GILLIS, J.M. (1996). Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl. Acad. Sci. U.S.A. 93, 3570-3574.
9. DELLORUSSO, C., CRAWFORD, R.W., CHAMBERLAIN, J.S., and BROOKS, S.V. (2001). Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury. J. Muscle Res. Cell Motil. 22, 467-475.
10. DELLORUSSO, C., SCOTT, J.M., HARTIGAN-O'CONNOR, D., SALVATORI, G., BARJOT, C., ROBINSON, A.S., CRAWFORD, R.W., BROOKS, S.V., and CHAMBERLAIN, J.S. (2002). Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proc. Natl. Acad. Sci. U.S.A. 99, 12974-12984.
11. DERER, W., EASWARAN, H.P., KNOPF, C.W., LEONHARDT, H., and CARDOSO, M.C. (1999). Direct protein transfer to terminally differentiated muscle cells. J. Mol. Med. 77, 609-613.
12. DEROSSI, D., JOLIOT, A.H., CHASSAING, G., and PROCHIANTZ, A. (1994). The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269, 10444-10450.
13. ELLIOTT, G., and O'HARE, P. (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88, 223-233.
14. FRANKEL, A.D., and PABO, C.O. (1988). Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
15. GILBERT, R., DUDLEY, R.W., LIU, A.B., PETROF, B.J., NALBANTOGLU, J., and KARPATI, G. (2003). Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin. Hum. Mol. Genet. 12, 1287-1299.
16. GILCHRIST, S.C., ONTELL, M.P., KOCHANEK, S., and CLEMENS, P.R. (2002). Immune response to full-length dystrophin delivered to Dmd muscle by a high-capacity adenoviral vector. Mol. Ther. 6, 359-368.
17. GRATTON, J.P., YU, J., GRIFFITH, J.W., BABBITT, R.W., SCOTLAND, R.S., HICKEY, R., GIORDANO, F.J., and SESSA, W.C. (2003). Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo. Nat. Med. 9, 357-362.
18. GREEN, M., and LOEWENSTEIN, P.M. (1988). Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein. Cell 55, 1179-1188.
19. HARPER, S.Q., HAUSER, M.A., DELLORUSSO, C., DUAN, D., CRAWFORD, R.W., PHELPS, S.F., HARPER, H.A., ROBINSON, A.S., ENGELHARDT, J.F., BROOKS, S.V., and CHAMBERLAIN, J.S. (2002). Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy. Nat. Med. 8, 253-261.
20. HOFFMAN, E.P., BROWN, R.H., JR., and KUNKEL, L.M. (1987). Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928.
21. JOLIOT, A., PERNELLE, C., DEAGOSTINI-BAZIN, H., and PROCHIANTZ, A. (1991) Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 88, 1864-1868.
22. KARPATI, G., HILTON-JONES, D., and GRIGGS, R.C. (2001). Disorders of Voluntary Muscle. (Cambridge University Press, Cambridge) pp. 385-432.
23. KOZARSKY, K.F., and WILSON, J.M. (1993). Gene therapy: Adenovirus vectors. Curr. Opin. Genet. Dev. 3, 499-503.
24. KRETZ, A., WYBRANIETZ, W.A., HERMENING, S., LAUER, U.M., and ISENMANN, S. (2003). HSV-1 VP22 augments adenoviral gene transfer to CNS neurons in the retina and striatum in vivo. Mol. Ther. 7, 659-669.
25. LEE, K.C., HAMSTRA, D.A., BULLARAYASAMUDRAM, S., BHOJANI, M.S., MOFFAT, B.A., DORNFELD, K.J., ROSS, B.D., and REHEMTULLA, A. (2006). Fusion of the HSV-1 tegument protein VP22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit. Gene Ther. 13, 127-137.
26. LIU, M., YUE, Y., HARPER, S.Q., GRANGE, R.W., CHAMBERLAIN, J.S., and DUAN, D. (2005). Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Mol. Ther. 11, 245-256.
27. LOCHMULLER, H., PETROF, B.J., PARI, C., LAROCHELLE, N., DODELET, V., WANG, Q., ALLEN, C., PRESCOTT, S., MASSIE, B., NALBANTOGLU, J., and KARPATI, G. (1996). Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Ther. 3, 706-716.
28. NALBANTOGLU, J., PARI, G., KARPATI, G., and HOLLAND, P.C. (1999). Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. Hum. Gene Ther. 10, 1009-1019.
29. + T cell deficiency. Hum. Gene Ther. 7, 1813-1826.
30. PHELPS, S.F., HAUSER, M.A., COLE, N.M., RAFAEL, J.A., HINKLE, R.T., FAULKNER, J.A., and CHAMBERLAIN, J.S. (1995). Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum. Mol. Genet. 4, 1251-1258.
31. ROEDER, G.E., PARISH, J.L., STERN, P.L., and GASTON, K. (2004). Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death. Biotechnol. Appl. Biochem. 40, 157-165.
32. VINCENT, N., RAGOT, T., GILGENKRANTZ, H., COUTON, D., CHAFEY, P., GREGOIRE, A., BRIAND, P., KAPLAN, J.C., KAHN, A., and PERRICAUDET, M. (1993). Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat. Genet. 5, 130-134.
33. WANG, S.H., ZHANG, C., CHEN, S.L., YU, M.J., ZHANG, Y.N., LI, M.S., XIONG, F., SHANG, Y.C., FENG, S.W., and SHEN, B.C. (2006). Transfection and in vitro expression of human microdystrophin gene in rat mesenchymal stem cells. Nan Fang Yi Ke Da Xue Xue Bao 26, 261-265.
34. WATCHKO, J., O'DAY, T., WANG, B., ZHOU, L., TANG, Y., LI, J., and XIAO, X. (2002). Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. Hum. Gene Ther. 13, 1451-1460.
35. YAMAMOTO, K., YUASA, K., MIYAGOE, Y., HOSAKA, Y., TSUKITA, K., YAMAMOTO, H., NABESHIMA, Y.I., and TAKEDA, S. (2000). Immune response to adenovirus-delivered antigens upregulates utrophin and results in mitigation of muscle pathology in mdx mice. Hum. Gene Ther. 11, 669-680.
36. YANG, L., LOCHMULLER, H., LUO, J., MASSIE, B., NALBANTOGLU, J., KARPATI, G., and PETROF, B.J. (1998). Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (mdx) mice. Gene Ther. 5, 369-379.
37. ZAVAGLIA, D., FAVROT, M.C., EYMIN, B., TENAUD, C., and COLL, J.L. (2003). Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein. Gene Ther. 10, 314-325.
38. ZENDER, L., KOCK, R., ECKHARD, M., FRERICKS, B., GOSLING, T., GEBHARDT, T., DROBEK, S., GALANSKI, M., KUHNEL, F., MANNS, M., and KUBICKA, S. (2002). Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors. Gastroenterology 123, 608-618.
39. ZUBRZYCKA-GAARN, E.E., BULMAN, D.E., KARPATI, C., BURGHES, A.H., BELFALL, B., KLAMUT, H.J., TALBOT, J., HODGES, R.S., RAY, P.N., and WORTON, R.G. (1988). The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 33, 466-469.